- Home
- CPT vs TXG Comparison
CPT vs TXG Comparison
Compare CPT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPT | TXG |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3B | 9.3B |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CPT | TXG |
|---|---|---|
| Price | $99.90 | $59.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 24 | 18 |
| Target Price | ★ $111.28 | $77.50 |
| AVG Volume (30 Days) | 776.6K | ★ 3.5M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.09% | N/A |
| EPS Growth | ★ 136.00 | 76.97 |
| EPS | ★ 0.59 | N/A |
| Revenue | $12,967,000.00 | ★ $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.82 | $10.11 |
| P/E Ratio | $177.08 | ★ N/A |
| Revenue Growth | ★ 81.69 | 68.06 |
| 52 Week Low | $95.30 | $15.12 |
| 52 Week High | $119.81 | $102.81 |
Technical Indicators
Market Signals| Indicator | CPT | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 37.21 |
| Support Level | $99.36 | $56.98 |
| Resistance Level | $103.71 | $63.82 |
| Average True Range (ATR) | 2.36 | 6.46 |
| MACD | 0.27 | -1.95 |
| Stochastic Oscillator | 28.07 | 6.65 |
Price Performance
Historical ComparisonAbout CPT Camden Property Trust
Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 175 multifamily properties comprised of nearly 59,921 apartment homes across the United States.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).